Wesbanco Bank Inc. Has $3.19 Million Stake in CVS Health Co. (NYSE:CVS)

Wesbanco Bank Inc. lessened its stake in CVS Health Co. (NYSE:CVS - Free Report) by 14.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 47,059 shares of the pharmacy operator's stock after selling 8,238 shares during the period. Wesbanco Bank Inc.'s holdings in CVS Health were worth $3,188,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the business. Stonebridge Financial Group LLC acquired a new position in shares of CVS Health during the 4th quarter worth about $28,000. Hopwood Financial Services Inc. purchased a new position in shares of CVS Health in the 4th quarter valued at $29,000. McIlrath & Eck LLC grew its holdings in shares of CVS Health by 32.6% during the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after buying an additional 174 shares during the last quarter. Financial Perspectives Inc increased its position in CVS Health by 137.5% during the 4th quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock worth $36,000 after purchasing an additional 466 shares during the period. Finally, Compass Planning Associates Inc acquired a new stake in shares of CVS Health during the 4th quarter valued at approximately $37,000. Institutional investors own 80.66% of the company's stock.

CVS Health Stock Performance

Shares of CVS Health stock traded up $0.35 on Tuesday, hitting $64.21. 5,529,420 shares of the company's stock were exchanged, compared to its average volume of 11,033,974. The stock has a market capitalization of $81.22 billion, a PE ratio of 17.54, a PEG ratio of 0.98 and a beta of 0.56. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $72.51. The company has a 50-day simple moving average of $65.13 and a 200-day simple moving average of $59.98. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81.

CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.63. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The firm had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. During the same quarter last year, the business earned $1.31 EPS. The business's revenue was up 7.0% on a year-over-year basis. As a group, equities analysts anticipate that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.14%. The ex-dividend date of this dividend was Tuesday, April 22nd. CVS Health's dividend payout ratio is currently 63.48%.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on CVS shares. Barclays set a $79.00 price objective on shares of CVS Health and gave the stock an "overweight" rating in a report on Monday, June 2nd. Robert W. Baird boosted their price objective on CVS Health from $51.00 to $71.00 and gave the company a "neutral" rating in a report on Tuesday, April 15th. JPMorgan Chase & Co. increased their target price on CVS Health from $80.00 to $81.00 and gave the stock an "overweight" rating in a research report on Tuesday, February 18th. Morgan Stanley reiterated an "overweight" rating on shares of CVS Health in a research report on Tuesday, April 15th. Finally, Leerink Partners raised shares of CVS Health from a "market perform" rating to an "outperform" rating and increased their target price for the company from $55.00 to $75.00 in a research note on Thursday, February 13th. Two investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $74.75.

Insider Transactions at CVS Health

In related news, Director Guy P. Sansone acquired 1,570 shares of the firm's stock in a transaction that occurred on Thursday, June 5th. The shares were purchased at an average price of $63.70 per share, with a total value of $100,009.00. Following the completion of the acquisition, the director now owns 12,007 shares in the company, valued at approximately $764,845.90. This represents a 15.04% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 1.22% of the company's stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.